Related Experiment Video
Updated: Jan 9, 2026

Detection of microRNA Expression in Peritoneal Membrane of Rats Using Quantitative Real-time PCR
Published on: June 27, 2017
Single-Cell RNA Sequencing Reveals Peritoneal Environment and New Insights into Fibrosis in a Continuous Ambulatory
Siqi Zheng1,2, Shanshan Deng3, Yan Yin1
1Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Guangdong Provincial Geriatrics Institute, Southern Medical University, Guangzhou, China.
Introduction:
Peritoneal fibrosis (PF) from long-term peritoneal dialysis (PD) is one of the main reasons for the ultrafiltration failure and the abandonment of PD in patients, and there is no effective treatment available. The dynamic changes in the PD microenvironment and their relationship to PD-related fibrosis remain unclear.
Methods:
We performed single-cell RNA sequencing (scRNA-seq) on overnight PD effluent collected from a continuous ambulatory PD (CAPD) patient at two critical time points: the initiation of dialysis and after 3 years of treatment, so as to reveal the dynamic changes of immune cells and peritoneal mesothelial cells (PMCs) during prolonged PD.
Results:
The results showed that six distinct populations of cells were identified within the PD effluent. The fibrotic progression exhibited a temporal shift in cellular dynamics: early-stage pathology was characterized by a sustained inflammatory response mediated primarily by macrophages, T cells, and PMCs, while late-stage pathogenesis transitioned to extracellular matrix (ECM) remodeling dominated by PMCs and fibroblasts.
Conclusion:
These findings demonstrate that different cell types and microenvironment contribute to initial injury responses and subsequent tissue remodeling of peritoneum, which provides a deeper comprehension for the mechanism in PF.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis I: Introduction and Procedure
Peritoneal Dialysis III: Nursing Management
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

